New diabetes shot shows promise in major trial
NCT ID NCT06778967
First seen Jan 05, 2026 · Last updated Apr 28, 2026 · Updated 19 times
Summary
This study tests a new medicine called GZR18 for people with type 2 diabetes whose blood sugar is not well controlled with current pills. About 1,100 Chinese adults will receive either GZR18 or another diabetes drug to see which works better at lowering blood sugar and body weight. The goal is to find a more effective treatment option for managing diabetes long-term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Tianjin Medical University General Hospital
Tianjin, China
Conditions
Explore the condition pages connected to this study.